Nonviral genetic modification mediates effective transgene expression and functional RNA interference in human mesenchymal stem cells

Journal of Gene Medicine

Volumn 7, Issue 6, 2005, Pages 718-728

  Hoelters, Juergen ^a   Ciccarella, Marisa ^a   Drechsel, Marei ^a   Geissler, Claudia ^a   Gülkan, Hülya ^a   Böcker, Wolfgang ^a   Schieker, Matthias ^a   Jochum, Marianne ^a   Neth, Peter ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Knock down; Mesenchymal stem cells; Nonviral transfection; RNA interference; Small interfering RNA; Stem cell therapy

Indexed keywords

DNA; ENHANCED GREEN FLUORESCENT PROTEIN; LIPOFECTAMINE; LIPOSOME; SMALL INTERFERING RNA;

ARTICLE; BONE; CARTILAGE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DNA MODIFICATION; GENE EXPRESSION; GENE SILENCING; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MESENCHYMAL STEM CELL; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA ISOLATION;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; FLUORESCEIN; FLUORESCENT DYES; GENE EXPRESSION; GENE SILENCING; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; HUMANS; MESENCHYMAL STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION; TRANSGENES;

EID: 21044459196     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.731     Document Type: Article

References (48)

1. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
2. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-49.
3. Bianco P, Robey PG. Stem cells in tissue engineering. Nature 2001; 414: 118-121.
4. Gafni Y, Turgeman G, Liebergal M, et al. Stem cells as vehicles for orthopedic gene therapy. Gene Ther 2004; 11: 417-426.
5. Chang SC, Chuang HL, Chen YR, et al. Ex vivo gene therapy in autologous bone marrow stromal stem cells for tissue-engineered maxillofacial bone regeneration. Gene Ther 2003; 10: 2013-2019.
6. Ramalho-Santos M, Yoon S, Matsuzaki Y, et al. "Stemness": transcriptional profiling of embryonic and adult stem cells. Science 2002; 298: 597-600.
7. Qi H, Aguiar DJ, Williams SM, et al. Identification of genes responsible for osteoblast differentiation from human mesodermal progenitor cells. Proc Natl Acad Sci U S A 2003; 100: 3305-3310.
8. Turgeman G, Aslan H, Gazit Z, et al. Cell-mediated gene therapy for bone formation and regeneration. Curr Opin Mol Ther 2002; 4: 390-394.
9. Lee K, Majumdar MK, Buyaner D, et al. Human mesenchymal stem cells maintain transgene expression during expansion and differentiation. Mol Ther 2001; 3: 857-866.
10. Zhang XY, La Russa VF, Reiser J. Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins. J Virol 2004; 78: 1219-1229.
11. Peister A, Mellad JA, Wang M, et al. Stable transfection of MSCs by electroporation. Gene Ther 2004; 11: 224-228.
12. Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494-498.
13. Dykxhoorn DM, Novina CD, Sharp PA. Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol 2003; 4: 457-467.
14. Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806-811.
15. Zamore PD, Tuschl T, Sharp PA, et al. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 2000; 101: 25-33.
16. Song E, Lee SK, Wang J, et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 2003; 9: 347-351.
17. Jacque JM, Triques K, Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature 2002; 418: 435-438.
18. Novina CD, Murray MF, Dykxhoorn DM, et al. siRNA-directed inhibition of HIV-1 infection. Nat Med 2002; 8: 681-686.
19. Lee NS, Dohjima T, Bauer G, et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 2002; 20: 500-505.
20. Stevenson M. Dissecting HIV-1 through RNA interference. Nat Rev Immunol 2003; 3: 851-858.
21. Ding H, Schwarz DS, Keene A, et al. Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis. Aging Cell 2003; 2: 209-217.
22. Chamberlain JR, Schwarze U, Wang PR, et al. Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science 2004; 303: 1198-1201.
23. Falk A, Holmstrom N, Carlen M, et al. Gene delivery to adult neural stem cells. Exp Cell Res 2002; 279: 34-39.
24. Gruneich JA, Price A, Zhu J, et al. Cationic corticosteroid for nonviral gene delivery. Gene Ther 2004; 11: 668-674.
25. Maurer N, Fenske DB, Cullis PR. Developments in liposomal drug delivery systems. Expert Opin Biol Ther 2001; 1: 923-947.
26. Stilwell JL, Samulski RJ. Role of viral vectors and virion shells in cellular gene expression. Mol Ther 2004; 9: 337-346.
27. Verma M. Viral genes and methylation. Ann N Y Acad Sci 2003; 983: 170-80: 170-180.
28. Svoboda J, Hejnar J, Geryk J, et al. Retroviruses in foreign species and the problem of provirus silencing. Gene 2000; 261: 181-188.
29. Wu X, Li Y, Crise B, et al. Transcription start regions in the human genome are favored targets for MLV integration. Science 2003; 300: 1749-1751.
30. Hacein-Bey-Abina S, von Kalle C, Schmidt M, et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003; 348: 255-256.
31. Hacein-Bey-Abina S, von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 415-419.
32. Baum C, von Kalle C, Staal FJ, et al. Chance or necessity? Insertional mutagenesis in gene therapy and its consequences. Mol Ther 2004; 9: 5-13.
33. Sadelain M. Insertional oncogenesis in gene therapy: how much of a risk? Gene Ther 2004; 11: 569-573.
34. Lakshmipathy U, Pelacho B, Sudo K, et al. Efficient transfection of embryonic and adult stem cells. Stem Cells 2004; 22: 531-543.
35. Weissinger F, Reimer P, Waessa T, et al. Gene transfer in purified human hematopoietic peripheral-blood stem cells by means of electroporation without prestimulation. J Lab Clin Med 2003; 141: 138-149.
36. Hamm A, Krott N, Breibach I, et al. Efficient transfection method for primary cells. Tissue Eng 2002; 8: 235-245.
37. Corsi K, Chellat F, Yahia L, et al. Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials 2003; 24: 1255-1264.
38. Van Craenenbroeck K, Vanhoenacker P, Haegeman G. Episomal vectors for gene expression in mammalian cells. Eur J Biochem 2000; 267: 5665-5678.
39. Colosimo A, Goncz KK, Holmes AR, et al. Transfer and expression of foreign genes in mammalian cells. Biotechniques 2000; 29: 314-331.
40. Tseng WC, Haselton FR, Giorgio TD. Transfection by cationic liposomes using simultaneous single cell measurements of plasmid delivery and transgene expression. J Biol Chem 1997; 272: 25 641-25 647.
41. McManus MT, Sharp PA. Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 2002; 3: 737-747.
42. Oliveira DM, Goodell MA. Transient RNA interference in hematopoietic progenitors with functional consequences. Genesis 2003; 36: 203-208.
43. Elbashir SM, Harborth J, Weber K, et al. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 2002; 26: 199-213.
44. Holen T, Amarzguioui M, Wiiger MT, et al. Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor. Nucleic Acids Res 2002; 30: 1757-1766.
45. Reynolds A, Leake D, Boese Q, et al. Rational siRNA design for RNA interference. Nat Biotechnol 2004; 22: 326-330.
46. Bridge AJ, Pebernard S, Ducraux A, et al. Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet 2003; 34: 263-264.
47. Sledz CA, Holko M, de Veer MJ, et al. Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 2003; 5: 834-839.
48. Niyibizi C, Wang S, Mi Z, et al. Gene therapy approaches for osteogenesis imperfecta. Gene Ther 2004; 11: 408-416.